Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $29,664 | $16,352 | $7,324 | $1,912 |
Gross Profit | 25,849 | 13,996 | 5,948 | 1,486 |
EBITDA | -55,665 | -66,902 | -73,485 | -65,470 |
EBIT | -55,858 | -67,093 | -73,682 | -65,684 |
Net Income | -74,451 | -85,577 | -91,446 | -82,852 |
Net Change In Cash | 29,664 | 16,352 | 7,324 | 1,912 |
Free Cash Flow | -63,461 | -63,487 | -70,767 | -69,060 |
Cash | 297,263 | 334,678 | 276,237 | 322,229 |
Basic Shares | 71,044 | 64,627 | 58,558 | 58,371 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $55,252 | $682 | $0 | $0 |
Gross Profit | 47,279 | 515 | -620 | -521 |
EBITDA | -261,522 | -159,049 | -171,820 | -134,559 |
EBIT | -262,317 | -159,624 | -172,440 | -135,080 |
Net Income | -334,326 | -201,592 | -223,006 | -148,094 |
Net Change In Cash | 55,252 | 682 | 0 | 0 |
Cost of Revenue | -104,237 | |||
Free Cash Flow | -266,770 | -139,214 | -147,571 | -148,945 |
Cash | 297,263 | 381,393 | 155,385 | 183,259 |
Basic Shares | 63,176 | 51,289 | 39,118 | 37,002 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.05 |
2024-09-30 | -$1.32 |
2024-06-30 | -$1.56 |
2024-03-31 | -$1.42 |
